|
US8409564B2
(en)
*
|
1999-10-05 |
2013-04-02 |
Universite De Montreal |
Rhodamine derivatives for photodynamic diagnosis and treatment
|
|
WO2001028581A1
(fr)
*
|
1999-10-20 |
2001-04-26 |
Chugai Seiyaku Kabushiki Kaisha |
Compositions medicinales pouvant inhiber gvhd
|
|
US20020127208A1
(en)
*
|
2000-08-31 |
2002-09-12 |
Waller Edmund K. |
Method of transplantation using chemotherapy-treated allogeneic cells that enhance immune responses without graft versus host disease
|
|
US6869956B2
(en)
|
2000-10-03 |
2005-03-22 |
Bristol-Myers Squibb Company |
Methods of treating inflammatory and immune diseases using inhibitors of IκB kinase (IKK)
|
|
EP1361896A2
(en)
*
|
2001-01-23 |
2003-11-19 |
Boston Scientific Corporation |
Localized myocardial injection method for treating ischemic myocardium
|
|
EP2316919B1
(en)
|
2001-02-14 |
2015-10-07 |
Anthrogenesis Corporation |
Post-partum mammalian placenta, its use and placental stem cells therefrom
|
|
CA2342675A1
(en)
*
|
2001-04-02 |
2002-10-02 |
Abdelkrim Habi |
Halogenated rhodamine derivatives and applications thereof
|
|
AU2002316448A1
(en)
*
|
2001-06-29 |
2003-03-03 |
The Government Of The United State Of America As Represent By The Secretary Of The Department Of Hea |
Method of promoting engraftment of a donor transplant in a recipient host
|
|
US7037900B2
(en)
*
|
2001-10-12 |
2006-05-02 |
Supergen, Inc. |
Composition and method for treating graft-versus-host disease
|
|
US7799324B2
(en)
*
|
2001-12-07 |
2010-09-21 |
Geron Corporation |
Using undifferentiated embryonic stem cells to control the immune system
|
|
US20040224403A1
(en)
*
|
2001-12-07 |
2004-11-11 |
Robarts Research Institute |
Reconstituting hematopoietic cell function using human embryonic stem cells
|
|
EP2186407A1
(en)
|
2002-02-13 |
2010-05-19 |
Anthrogenesis Corporation |
Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
|
|
US7498171B2
(en)
|
2002-04-12 |
2009-03-03 |
Anthrogenesis Corporation |
Modulation of stem and progenitor cell differentiation, assays, and uses thereof
|
|
CA105900S
(en)
|
2003-08-12 |
2006-10-19 |
180S Inc |
Frame for ear warmer
|
|
AU2004294243B2
(en)
*
|
2003-12-05 |
2011-02-17 |
Hopital Maisonneuve-Rosemont |
Immunologic compounds for prevention, protection, prophylaxis or treatment of immunological disorders, infections and cancer
|
|
JP2006081542A
(ja)
*
|
2004-08-18 |
2006-03-30 |
Institute Of Physical & Chemical Research |
クローン哺乳動物の作成方法
|
|
WO2006057951A2
(en)
*
|
2004-11-22 |
2006-06-01 |
Beth Israel Deaconess Medical Center |
Methods and compositions for the treatment of graft failure
|
|
EP1940389A2
(en)
|
2005-10-21 |
2008-07-09 |
Braincells, Inc. |
Modulation of neurogenesis by pde inhibition
|
|
AU2006308889A1
(en)
|
2005-10-31 |
2007-05-10 |
Braincells, Inc. |
GABA receptor mediated modulation of neurogenesis
|
|
CN101389754A
(zh)
|
2005-12-29 |
2009-03-18 |
人类起源公司 |
胎盘干细胞和第二来源干细胞的联合培养
|
|
PT2471904T
(pt)
|
2005-12-29 |
2019-02-25 |
Celularity Inc |
População de células estaminais placentárias
|
|
US20100216734A1
(en)
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
EP2382975A3
(en)
|
2006-05-09 |
2012-02-29 |
Braincells, Inc. |
Neurogenesis by modulating angiotensin
|
|
US20090197823A1
(en)
*
|
2006-05-09 |
2009-08-06 |
Braincells, Inc. |
Aliskiren modulation of neurogenesis
|
|
JP2009536667A
(ja)
|
2006-05-09 |
2009-10-15 |
ブレインセルス，インコーポレイティド |
５ｈｔ受容体介在性の神経新生
|
|
AU2007292848A1
(en)
|
2006-09-08 |
2008-03-13 |
Braincells, Inc. |
Combinations containing a 4-acylaminopyridine derivative
|
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
|
ZA200902233B
(en)
|
2006-10-23 |
2010-07-28 |
Anthrogenesis Corp |
Methods and compositions for treatment of bone defects with placental cell populations
|
|
WO2008083204A2
(en)
*
|
2006-12-28 |
2008-07-10 |
Braincells, Inc. |
Modulation of neurogenesis by melatoninergic ligands
|
|
AU2008204800A1
(en)
*
|
2007-01-11 |
2008-07-17 |
Braincells, Inc. |
Modulation of neurogenesis with use of modafinil
|
|
US20080188457A1
(en)
*
|
2007-02-02 |
2008-08-07 |
Braincells, Inc. |
Modulation of Neurogenesis with Biguanides and GSK3-beta Agents
|
|
WO2009123877A1
(en)
*
|
2008-03-21 |
2009-10-08 |
Braincells, Inc. |
A method of treating a nervous system disorder by modulation of neurogenesis with mcc-257
|
|
CA2734446C
(en)
|
2008-08-22 |
2017-06-20 |
Anthrogenesis Corporation |
Methods and compositions for treatment of bone defects with placental cell populations
|
|
WO2010099217A1
(en)
|
2009-02-25 |
2010-09-02 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
|
MX2012011543A
(es)
|
2010-04-08 |
2013-05-06 |
Anthrogenesis Corp |
Tratamiento de sarcoidosis empleando celulas madre placentarias.
|
|
US8969315B2
(en)
|
2010-12-31 |
2015-03-03 |
Anthrogenesis Corporation |
Enhancement of placental stem cell potency using modulatory RNA molecules
|
|
JP6104896B2
(ja)
|
2011-06-01 |
2017-03-29 |
アントフロゲネシス コーポレーション |
胎盤幹細胞を使用する疼痛の治療
|
|
WO2023277114A1
(ja)
*
|
2021-07-02 |
2023-01-05 |
公益財団法人神戸医療産業都市推進機構 |
放射線照射造血幹細胞を含む医薬組成物
|